메뉴 건너뛰기




Volumn 209, Issue 6, 2009, Pages 279-302

European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish Adaptation;Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008

Author keywords

Cardiovascular diseases; Cardiovascular prevention; Cardiovascular risk

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

EID: 67649522749     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/S0014-2565(09)71477-8     Document Type: Article
Times cited : (17)

References (89)
  • 1
    • 35148892823 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice: fourth joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
    • Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: fourth joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 28 (2007) 2375-2414
    • (2007) Eur J Cardiovasc Prev Rehabil , vol.28 , pp. 2375-2414
    • Graham, I.1    Atar, D.2    Borch-Johnsen, K.3    Boysen, G.4    Burell, G.5    Cifkova, R.6
  • 2
    • 42449144309 scopus 로고    scopus 로고
    • Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: versión resumida
    • Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: versión resumida. Rev Esp Cardiol 61 (2008) 82.e1-82.e49
    • (2008) Rev Esp Cardiol , vol.61
    • Graham, I.1    Atar, D.2    Borch-Johnsen, K.3    Boysen, G.4    Burell, G.5    Cifkova, R.6
  • 3
    • 11144328988 scopus 로고    scopus 로고
    • Nuevas estrategias en prevención cardiovascular
    • Lobos J.M., and Brotons C. Nuevas estrategias en prevención cardiovascular. Aten Primaria 34 (2004) 389-391
    • (2004) Aten Primaria , vol.34 , pp. 389-391
    • Lobos, J.M.1    Brotons, C.2
  • 6
    • 67649470868 scopus 로고    scopus 로고
    • Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Madrid: Ministerio de Sanidad y Consumo; 2004.
    • Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Madrid: Ministerio de Sanidad y Consumo; 2004.
  • 7
    • 4344575902 scopus 로고    scopus 로고
    • Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice
    • De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardio Prev Rev 10 Suppl1 (2003) S1-S78
    • (2003) Eur J Cardio Prev Rev , vol.10 , Issue.SUPPL.1
    • De Backer, G.1    Ambrosioni, E.2    Borch-Johnsen, K.3    Brotons, C.4    Cifkova, R.5    Dallongeville, J.6
  • 8
    • 34250897337 scopus 로고    scopus 로고
    • Calibración de la tabla SCORE de riesgo cardiovascular para España
    • Sans S., Fitzgerald A.P., Royo D., Conroy R., and Grahan I. Calibración de la tabla SCORE de riesgo cardiovascular para España. Rev Esp Cardiol 60 (2007) 476-485
    • (2007) Rev Esp Cardiol , vol.60 , pp. 476-485
    • Sans, S.1    Fitzgerald, A.P.2    Royo, D.3    Conroy, R.4    Grahan, I.5
  • 9
    • 67649467815 scopus 로고    scopus 로고
    • Instituto Nacional de Estadística. Defunciones según la Causa de Muerte 2006 Tablas Nacionales. Defunciones por causas (lista reducida), sexo y edad. [Acceso 2008] Disponible en: http://www.ine.es/inebase/cgi/axi
    • Instituto Nacional de Estadística. Defunciones según la Causa de Muerte 2006 Tablas Nacionales. Defunciones por causas (lista reducida), sexo y edad. [Acceso 2008] Disponible en: http://www.ine.es/inebase/cgi/axi
  • 14
    • 0019794526 scopus 로고
    • The strategy of prevention: lessons from cardiovascular disease
    • Rose G. The strategy of prevention: lessons from cardiovascular disease. BMJ 282 (1981) 1847-1851
    • (1981) BMJ , vol.282 , pp. 1847-1851
    • Rose, G.1
  • 15
    • 0028071980 scopus 로고
    • Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and the European Society of Hypertension
    • Pyorala K., De Backer G., Graham I., Poole-Wilson P., and Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and the European Society of Hypertension. Atherosclerosis 110 (1994) 121-161
    • (1994) Atherosclerosis , vol.110 , pp. 121-161
    • Pyorala, K.1    De Backer, G.2    Graham, I.3    Poole-Wilson, P.4    Wood, D.5
  • 16
    • 0032189666 scopus 로고    scopus 로고
    • Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on coronary prevention
    • Wood D., De Backer G., Faergeman O., Graham I., Mancia G., and Pyorala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on coronary prevention. Eur Heart J 19 (1998) 1434-1503
    • (1998) Eur Heart J , vol.19 , pp. 1434-1503
    • Wood, D.1    De Backer, G.2    Faergeman, O.3    Graham, I.4    Mancia, G.5    Pyorala, K.6
  • 17
    • 0038579421 scopus 로고    scopus 로고
    • Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
    • SCORE project group
    • Conroy R., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al., SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003) 987-1003
    • (2003) Eur Heart J , vol.24 , pp. 987-1003
    • Conroy, R.1    Pyörälä, K.2    Fitzgerald, A.P.3    Sans, S.4    Menotti, A.5    De Backer, G.6
  • 19
    • 67649461041 scopus 로고    scopus 로고
    • The Health Benefits of Smoking Cessation. Washington: US Department of Health and Human Services; 1990.
    • The Health Benefits of Smoking Cessation. Washington: US Department of Health and Human Services; 1990.
  • 21
    • 0034504237 scopus 로고    scopus 로고
    • Subcutanuous and visceral adipose tissue: their relation to the metabolic syndrome
    • Wajchenberg B. Subcutanuous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 (2000) 697-738
    • (2000) Endocr Rev , vol.21 , pp. 697-738
    • Wajchenberg, B.1
  • 23
    • 0004318660 scopus 로고    scopus 로고
    • World Health Organization Consultation of Obesity, Division of Non-communicable Diseases, Programme of Nutrition, Family and Reproductive Health, WHO, Geneva
    • World Health Organization Consultation of Obesity. Obesity: Preventing and Managing the Global Epidemic (1998), Division of Non-communicable Diseases, Programme of Nutrition, Family and Reproductive Health, WHO, Geneva
    • (1998) Obesity: Preventing and Managing the Global Epidemic
  • 24
    • 0032162184 scopus 로고    scopus 로고
    • Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults
    • National Heart, Lung, and Blood Institute Obesity Education Initative Expert Panel
    • National Heart, Lung, and Blood Institute Obesity Education Initative Expert Panel. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Obes Res 6 (1998) S51-S209
    • (1998) Obes Res , vol.6
  • 26
    • 2342589486 scopus 로고    scopus 로고
    • Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials
    • Taylor R., Brown A., Ebrahim S., Jolliffe J., Noorani H., Rees K., et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116 (2004) 682-692
    • (2004) Am J Med , vol.116 , pp. 682-692
    • Taylor, R.1    Brown, A.2    Ebrahim, S.3    Jolliffe, J.4    Noorani, H.5    Rees, K.6
  • 27
    • 0025234906 scopus 로고
    • Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
    • MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
    • (1990) Lancet , vol.335 , pp. 765-774
    • MacMahon, S.1    Peto, R.2    Cutler, J.3    Collins, R.4    Sorlie, P.5    Neaton, J.6
  • 29
    • 0035904776 scopus 로고    scopus 로고
    • Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study
    • Vasan R., Larson M.G., Leip E.P., Kannel W.B., and Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 358 (2001) 1682-1686
    • (2001) Lancet , vol.358 , pp. 1682-1686
    • Vasan, R.1    Larson, M.G.2    Leip, E.P.3    Kannel, W.B.4    Levy, D.5
  • 30
    • 34250350040 scopus 로고    scopus 로고
    • 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hyperten 25 (2007) 1105-1187
    • (2007) J Hyperten , vol.25 , pp. 1105-1187
    • Mancia, G.1    De Backer, G.2    Dominiczak, A.3    Cifkova, R.4    Fagard, R.5    Germano, G.6
  • 31
    • 0035968623 scopus 로고    scopus 로고
    • Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
    • PROGRESS Collaborative Group
    • PROGRESS Collaborative Group. Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
    • (2001) Lancet , vol.358 , pp. 1033-1041
  • 32
    • 0034700790 scopus 로고    scopus 로고
    • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and micro-HOPE substudy
    • HOPE: Heart Outcomes Prevention Evaluation Study Investigators
    • HOPE: Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and micro-HOPE substudy. Lancet 355 (2000) 253-259
    • (2000) Lancet , vol.355 , pp. 253-259
  • 33
    • 28844504752 scopus 로고    scopus 로고
    • Effects of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis
    • Casas J., Chua W., Loukogeorgakis S., Vallance P., Smeeth L., Hingorani A.R., et al. Effects of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366 (2005) 2026-2033
    • (2005) Lancet , vol.366 , pp. 2026-2033
    • Casas, J.1    Chua, W.2    Loukogeorgakis, S.3    Vallance, P.4    Smeeth, L.5    Hingorani, A.R.6
  • 34
    • 0037160968 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
    • LIFE Study Group
    • Dahlöf B., Devereux R.B., Kjeldsen S.E., Julius S., Beevers G., De Faire U., et al., LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 995-1003
    • (2002) Lancet , vol.359 , pp. 995-1003
    • Dahlöf, B.1    Devereux, R.B.2    Kjeldsen, S.E.3    Julius, S.4    Beevers, G.5    De Faire, U.6
  • 35
    • 29244436688 scopus 로고    scopus 로고
    • New-onset diabetes and antihypertensive drugs
    • Mancia G., Grassi G., and Zancheti A. New-onset diabetes and antihypertensive drugs. J Hypertens 24 (2006) 3-10
    • (2006) J Hypertens , vol.24 , pp. 3-10
    • Mancia, G.1    Grassi, G.2    Zancheti, A.3
  • 37
    • 0038581685 scopus 로고    scopus 로고
    • Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension
    • Office versus Ambulatory Pressure Study Investigators
    • Clement D., De Buyzere M.L., De Bacquer D.A., De Leeuw P.W., Duprez D.A., Fagard R.H., et al., Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med 348 (2003) 2407-2415
    • (2003) N Engl J Med , vol.348 , pp. 2407-2415
    • Clement, D.1    De Buyzere, M.L.2    De Bacquer, D.A.3    De Leeuw, P.W.4    Duprez, D.A.5    Fagard, R.H.6
  • 40
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    • Cholesterol Treatment Trialists' (CTT) Collaborators
    • Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al., Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
    • (2005) Lancet , vol.366 , pp. 1267-1278
    • Baigent, C.1    Keech, A.2    Kearney, P.M.3    Blackwell, L.4    Buck, G.5    Pollicino, C.6
  • 41
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo controlled trial
    • CARDS investigators
    • Colhoun H., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., et al., CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo controlled trial. Lancet 364 (2004) 685-696
    • (2004) Lancet , vol.364 , pp. 685-696
    • Colhoun, H.1    Betteridge, D.J.2    Durrington, P.N.3    Hitman, G.A.4    Neil, H.A.5    Livingstone, S.J.6
  • 42
    • 26844447541 scopus 로고    scopus 로고
    • Early and late benefit of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE-IT-TIMI22 trial
    • PROVE IT-TIMI 22 Investigators
    • Ray K., Cannon C.P., McCabe C.H., Cairns R., Tonkin A.M., Sacks F.M., et al., PROVE IT-TIMI 22 Investigators. Early and late benefit of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE-IT-TIMI22 trial. J Am Coll Cardiol 46 (2005) 1405-1410
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1405-1410
    • Ray, K.1    Cannon, C.P.2    McCabe, C.H.3    Cairns, R.4    Tonkin, A.M.5    Sacks, F.M.6
  • 43
    • 33645524176 scopus 로고    scopus 로고
    • Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
    • Nissen S., Nicholls S.J., Sipahi I., Libby P., Raichlen J.S., Ballantyne C.M., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
    • (2006) JAMA , vol.295 , pp. 1556-1565
    • Nissen, S.1    Nicholls, S.J.2    Sipahi, I.3    Libby, P.4    Raichlen, J.S.5    Ballantyne, C.M.6
  • 44
    • 33846414720 scopus 로고    scopus 로고
    • Task Force on Diabetes and Cardiovascular Disenses of the European Society of Cardiology (ESC); European Associatión for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summuty. The task force on Diabetes and Dardiovascular Diseases of the ESC and the EASD
    • Rydén L., Standl E., Bartnik M., Van der Berghe G., Betteridge J., De Boer M.J., et al. Task Force on Diabetes and Cardiovascular Disenses of the European Society of Cardiology (ESC); European Associatión for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summuty. The task force on Diabetes and Dardiovascular Diseases of the ESC and the EASD. Eur Heart J 28 (2007) 88-136
    • (2007) Eur Heart J , vol.28 , pp. 88-136
    • Rydén, L.1    Standl, E.2    Bartnik, M.3    Van der Berghe, G.4    Betteridge, J.5    De Boer, M.J.6
  • 45
    • 45149133036 scopus 로고    scopus 로고
    • Intensive Blood Gludose Control and Vascular Outcomes in Patients with Tipe 2 Diabetes
    • The ADVANCE Collaborative Group
    • The ADVANCE Collaborative Group. Intensive Blood Gludose Control and Vascular Outcomes in Patients with Tipe 2 Diabetes. N Engl J Med 358 (2008) 2560
    • (2008) N Engl J Med , vol.358 , pp. 2560
  • 46
    • 45149131667 scopus 로고    scopus 로고
    • Effects of Intensive Glucose Lowering in Type 2 Diabetes
    • The Action to Control Cardiovascular Risk in Diabetes Study Group
    • The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 358 (2008) 2545-2559
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
  • 47
    • 25144459980 scopus 로고    scopus 로고
    • The metabolic syndrome-a new worldwide definition
    • IDF Epidemiology Task Force Consensus Group
    • Alberti K., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
    • (2005) Lancet , vol.366 , pp. 1059-1062
    • Alberti, K.1    Zimmet, P.2    Shaw, J.3
  • 49
    • 0037022910 scopus 로고    scopus 로고
    • Inflammation and atherosclerosis
    • Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
    • (2002) Circulation , vol.105 , pp. 1135-1143
    • Libby, P.1    Ridker, P.M.2    Maseri, A.3
  • 50
    • 0034704893 scopus 로고    scopus 로고
    • C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
    • Ridker P., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
    • (2000) N Engl J Med , vol.342 , pp. 836-843
    • Ridker, P.1    Hennekens, C.H.2    Buring, J.E.3    Rifai, N.4
  • 52
    • 33645456050 scopus 로고    scopus 로고
    • Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture
    • Lowe G. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 133 (2006) 232-250
    • (2006) Br J Haematol , vol.133 , pp. 232-250
    • Lowe, G.1
  • 53
    • 1842587885 scopus 로고    scopus 로고
    • C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
    • Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
    • (2004) N Engl J Med , vol.350 , pp. 1387-1397
    • Danesh, J.1    Wheeler, J.G.2    Hirschfield, G.M.3    Eda, S.4    Eiriksdottir, G.5    Rumley, A.6
  • 54
    • 14544297938 scopus 로고    scopus 로고
    • Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans
    • Geelen A., Brouwer I.A., Schouten E.G., Maan A.C., Katan M.B., and Zock P.L. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 81 (2005) 416-420
    • (2005) Am J Clin Nutr , vol.81 , pp. 416-420
    • Geelen, A.1    Brouwer, I.A.2    Schouten, E.G.3    Maan, A.C.4    Katan, M.B.5    Zock, P.L.6
  • 55
    • 0025167629 scopus 로고
    • Parental history is an independent risk factor for coronary artery disease: the Framingham Study
    • Myers R., Kiely D.K., Cupples L.A., and Kannel W.B. Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J 120 (1990) 963-969
    • (1990) Am Heart J , vol.120 , pp. 963-969
    • Myers, R.1    Kiely, D.K.2    Cupples, L.A.3    Kannel, W.B.4
  • 56
    • 0015515790 scopus 로고
    • Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives
    • Patterson D., and Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet 1 (1972) 393-399
    • (1972) Lancet , vol.1 , pp. 393-399
    • Patterson, D.1    Slack, J.2
  • 57
    • 20344376649 scopus 로고    scopus 로고
    • Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA
    • Holla O., Teie C., Berge K.E., and Leren T.P. Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA. Clin Chim Acta 356 (2005) 164-171
    • (2005) Clin Chim Acta , vol.356 , pp. 164-171
    • Holla, O.1    Teie, C.2    Berge, K.E.3    Leren, T.P.4
  • 58
    • 0035197537 scopus 로고    scopus 로고
    • Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis
    • Heath K., Gahan M., Whittall R.A., and Humphries S.E. Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis. Atherosclerosis 154 (2001) 243-246
    • (2001) Atherosclerosis , vol.154 , pp. 243-246
    • Heath, K.1    Gahan, M.2    Whittall, R.A.3    Humphries, S.E.4
  • 59
    • 0035058910 scopus 로고    scopus 로고
    • A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom
    • Heath K., Humphries S.E., Middleton-Price H., and Boxer M. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom. Eur J Hum Genet 9 (2001) 244-252
    • (2001) Eur J Hum Genet , vol.9 , pp. 244-252
    • Heath, K.1    Humphries, S.E.2    Middleton-Price, H.3    Boxer, M.4
  • 61
    • 0037154285 scopus 로고    scopus 로고
    • Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study
    • Assmann G., Cullen P., and Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105 (2002) 310-315
    • (2002) Circulation , vol.105 , pp. 310-315
    • Assmann, G.1    Cullen, P.2    Schulte, H.3
  • 62
    • 33646433424 scopus 로고    scopus 로고
    • Differential diagnosis of familial high density lipoprotein deficiency syndromes
    • Von Eckardstein A. Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis 186 (2006) 231-239
    • (2006) Atherosclerosis , vol.186 , pp. 231-239
    • Von Eckardstein, A.1
  • 63
    • 0032414773 scopus 로고    scopus 로고
    • Electrocardiogram-correlated image reconstruction from subsecond spiral computed tomography scans of the heart
    • Kachelriess M., and Kalender W.A. Electrocardiogram-correlated image reconstruction from subsecond spiral computed tomography scans of the heart. Med Phys 25 (1998) 2417-2431
    • (1998) Med Phys , vol.25 , pp. 2417-2431
    • Kachelriess, M.1    Kalender, W.A.2
  • 64
    • 26244459123 scopus 로고    scopus 로고
    • Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease
    • Tedeschi-Reiner E., Strozzi M., Skoric B., and Reiner Z. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol 96 (2005) 1107-1109
    • (2005) Am J Cardiol , vol.96 , pp. 1107-1109
    • Tedeschi-Reiner, E.1    Strozzi, M.2    Skoric, B.3    Reiner, Z.4
  • 65
    • 33645504844 scopus 로고    scopus 로고
    • Cardiovascular disease in women: a statement from the policy conference of the European Society of Cardiology
    • Stramba-Badiale M., Fox K.M., Priori S.G., Collins P., Daly C., Graham I., et al. Cardiovascular disease in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 27 (2006) 994-1005
    • (2006) Eur Heart J , vol.27 , pp. 994-1005
    • Stramba-Badiale, M.1    Fox, K.M.2    Priori, S.G.3    Collins, P.4    Daly, C.5    Graham, I.6
  • 66
    • 33846031473 scopus 로고    scopus 로고
    • Kidney-heart interactions: epidemiology, pathogenesis, and treatment
    • Berl T., and Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1 (2006) 8-18
    • (2006) Clin J Am Soc Nephrol , vol.1 , pp. 8-18
    • Berl, T.1    Henrich, W.2
  • 67
    • 1442334070 scopus 로고    scopus 로고
    • Predictors of new-onset kidney disease in a community-based population
    • Fox C., Larson M.G., Leip E.P., Culleton B., Wilson P.W.F., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
    • (2004) JAMA , vol.291 , pp. 844-850
    • Fox, C.1    Larson, M.G.2    Leip, E.P.3    Culleton, B.4    Wilson, P.W.F.5    Levy, D.6
  • 68
    • 33748934452 scopus 로고    scopus 로고
    • Cardiometabolic syndrome and chronic kidney disease: what is the link?
    • Sarafidis P., Whaley-Connell, Sowers J., and Bakris G.L. Cardiometabolic syndrome and chronic kidney disease: what is the link?. JCMS 1 (2006) 58-65
    • (2006) JCMS , vol.1 , pp. 58-65
    • Sarafidis, P.1    Whaley-Connell2    Sowers, J.3    Bakris, G.L.4
  • 69
    • 5644266226 scopus 로고    scopus 로고
    • The association among renal insufficiency, pharmacotherapy and outcomes in 6247 patients with heart failure and coronary artery disease
    • Ezekowitz J., McAlister F.A., Humphries K.H., Norris C.M., Tonelli M., Ghali W.A., et al. The association among renal insufficiency, pharmacotherapy and outcomes in 6247 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44 (2004) 1587-1592
    • (2004) J Am Coll Cardiol , vol.44 , pp. 1587-1592
    • Ezekowitz, J.1    McAlister, F.A.2    Humphries, K.H.3    Norris, C.M.4    Tonelli, M.5    Ghali, W.A.6
  • 70
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk people
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk people. BMJ 324 (2002) 71-86
    • (2002) BMJ , vol.324 , pp. 71-86
  • 71
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation
    • CURE Trial Investigators
    • CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. N Engl J Med 345 (2001) 494-502
    • (2001) N Engl J Med , vol.345 , pp. 494-502
  • 72
    • 20144373281 scopus 로고    scopus 로고
    • Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
    • Sabatine M.S., Cannon C.P., Gibson C.M., Lopez-Sendon J.L., Montalescot G., Theroux P., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
    • (2005) N Engl J Med , vol.352 , pp. 1179-1189
    • Sabatine, M.S.1    Cannon, C.P.2    Gibson, C.M.3    Lopez-Sendon, J.L.4    Montalescot, G.5    Theroux, P.6
  • 73
    • 33645861080 scopus 로고    scopus 로고
    • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
    • The CHARISMA Investigators
    • Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E., et al., The CHARISMA Investigators. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med 354 (2006) 1-12
    • (2006) N Engl J Med , vol.354 , pp. 1-12
    • Bhatt, D.L.1    Fox, K.A.2    Hacke, W.3    Berger, P.B.4    Black, H.R.5    Boden, W.E.6
  • 74
    • 3242770664 scopus 로고    scopus 로고
    • Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, doubleblind, placebo-controlled trial
    • Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, doubleblind, placebo-controlled trial. Lancet 364 (2004) 331-337
    • (2004) Lancet , vol.364 , pp. 331-337
    • Diener, H.C.1    Bogousslavsky, J.2    Brass, L.M.3    Cimminiello, C.4    Csiba, L.5    Kaste, M.6
  • 75
    • 0034763373 scopus 로고    scopus 로고
    • Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
    • Sanmuganathan P.S., Ghahramani P., Jackson P.R., Wallis E.J., and Ramsay L.E. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 85 (2001) 265-271
    • (2001) Heart , vol.85 , pp. 265-271
    • Sanmuganathan, P.S.1    Ghahramani, P.2    Jackson, P.R.3    Wallis, E.J.4    Ramsay, L.E.5
  • 76
    • 0000093848 scopus 로고    scopus 로고
    • Betablokade after myocardial infarction: systematic review and meta regression analysis
    • Freemantle N., Cleland J., Young P., Mason J., and Harrison J. Betablokade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
    • (1999) BMJ , vol.318 , pp. 1730-1737
    • Freemantle, N.1    Cleland, J.2    Young, P.3    Mason, J.4    Harrison, J.5
  • 77
    • 0035799381 scopus 로고    scopus 로고
    • Beta-blokers in congestive Heart Failure. A Bayesian meta-analysis
    • Brophy J.M., Joseph L., and Rouleau J.L. Beta-blokers in congestive Heart Failure. A Bayesian meta-analysis. Ann Intern Med 134 (2001) 550-560
    • (2001) Ann Intern Med , vol.134 , pp. 550-560
    • Brophy, J.M.1    Joseph, L.2    Rouleau, J.L.3
  • 78
    • 0010838455 scopus 로고    scopus 로고
    • The ACE-inhibitor Myocardial Infarction Collaborative Group
    • Flather M.D., Yusuf Y., Kober L., Pfeffer M., Hall A., Murray G., et al., The ACE-inhibitor Myocardial Infarction Collaborative Group. Lancet 355 (2000) 1575-1581
    • (2000) Lancet , vol.355 , pp. 1575-1581
    • Flather, M.D.1    Yusuf, Y.2    Kober, L.3    Pfeffer, M.4    Hall, A.5    Murray, G.6
  • 79
    • 0032499670 scopus 로고    scopus 로고
    • Indication for ACE Inhibitors in the early treatment of acute myocardial infartion: systematic overview of individual data from 100.000 patients in randomized trials
    • ACE Inhibitor Myocardial Infartion Collaborative Group
    • ACE Inhibitor Myocardial Infartion Collaborative Group. Indication for ACE Inhibitors in the early treatment of acute myocardial infartion: systematic overview of individual data from 100.000 patients in randomized trials. Circulation 97 (1998) 2202-2212
    • (1998) Circulation , vol.97 , pp. 2202-2212
  • 80
    • 20444427156 scopus 로고    scopus 로고
    • Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES)
    • Schrader J., Luders S., Kulschewski A., Hammersen F., Plate K., Berger J., et al. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 36 (2005) 1218-1222
    • (2005) Stroke , vol.36 , pp. 1218-1222
    • Schrader, J.1    Luders, S.2    Kulschewski, A.3    Hammersen, F.4    Plate, K.5    Berger, J.6
  • 81
    • 7244227872 scopus 로고    scopus 로고
    • Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High Risk Acute Myocardial Infarction
    • Lee V.C., Rhew D.C., Dylan M., Badamgarav E., Braunstein G.D., and Weingarten S.R. Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High Risk Acute Myocardial Infarction. Ann Intern Med 141 (2004) 693-704
    • (2004) Ann Intern Med , vol.141 , pp. 693-704
    • Lee, V.C.1    Rhew, D.C.2    Dylan, M.3    Badamgarav, E.4    Braunstein, G.D.5    Weingarten, S.R.6
  • 82
    • 42049107348 scopus 로고    scopus 로고
    • Telmisartan, ramipril or both in patient ar high risk for vascular events
    • The ONTARGET Investigators
    • The ONTARGET Investigators. Telmisartan, ramipril or both in patient ar high risk for vascular events. N Engl J Med 358 (2008) 1547-1559
    • (2008) N Engl J Med , vol.358 , pp. 1547-1559
  • 83
    • 33947517400 scopus 로고    scopus 로고
    • Por el comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Guía para el tratamiento preventivo de la isquemia cerebral
    • Díez Tejedor E. (Ed), Prous Science, Barcelona
    • Diez Tejedor E., Fuentes B., Gil Núñez A.C., Gil Peralta A., and Matías Guiu J. Por el comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Guía para el tratamiento preventivo de la isquemia cerebral. In: Díez Tejedor E. (Ed). Guía para el diagnostico y tratamiento del ictus (2006), Prous Science, Barcelona 133-183
    • (2006) Guía para el diagnostico y tratamiento del ictus , pp. 133-183
    • Diez Tejedor, E.1    Fuentes, B.2    Gil Núñez, A.C.3    Gil Peralta, A.4    Matías Guiu, J.5
  • 84
    • 67649462125 scopus 로고    scopus 로고
    • EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention programmes: a comparison of EUROASPIRE I & II in 9 countries. EUROASPIRE I & II Group. European Action on Secondary prevention by Intervention to Reduce Events. Lancet. 2001;357:995-1001
    • EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention programmes: a comparison of EUROASPIRE I & II in 9 countries. EUROASPIRE I & II Group. European Action on Secondary prevention by Intervention to Reduce Events. Lancet. 2001;357:995-1001.
  • 85
    • 61849116330 scopus 로고    scopus 로고
    • Cardiovascular Prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
    • The EUROASPIRE Study Group
    • Kotseva K., Wood D., De Backer G., De Bacquer D., Pyorala K., Keil U., and The EUROASPIRE Study Group. Cardiovascular Prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373 (2009) 929-940
    • (2009) Lancet , vol.373 , pp. 929-940
    • Kotseva, K.1    Wood, D.2    De Backer, G.3    De Bacquer, D.4    Pyorala, K.5    Keil, U.6
  • 86
    • 44449132726 scopus 로고    scopus 로고
    • Determinantes del control de la presión arterial y los lípidos en pacientes con enfermedad cardiovascular (estudio PREseAP)
    • Representación de los investigadores del estudio PREseAP
    • Orozco-Beltrán D., Brotons C., Moral I., Soriano N., Del Valle M.A., Rodríguez A.I., et al., Representación de los investigadores del estudio PREseAP. Determinantes del control de la presión arterial y los lípidos en pacientes con enfermedad cardiovascular (estudio PREseAP). Rev Esp Cardiol 61 (2008) 317-321
    • (2008) Rev Esp Cardiol , vol.61 , pp. 317-321
    • Orozco-Beltrán, D.1    Brotons, C.2    Moral, I.3    Soriano, N.4    Del Valle, M.A.5    Rodríguez, A.I.6
  • 87
    • 63149163469 scopus 로고    scopus 로고
    • Diagnóstico y prevención secundaria del infarto cerebral en España. Estudio DIAPRESIC
    • Nombre el Proyecto Ictus del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología.
    • Gil-Núñez A., Vivancos J., Gabriel R., and Nombre el Proyecto Ictus del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Diagnóstico y prevención secundaria del infarto cerebral en España. Estudio DIAPRESIC. Med Clin (Barc) 131 (2008) 765-769
    • (2008) Med Clin (Barc) , vol.131 , pp. 765-769
    • Gil-Núñez, A.1    Vivancos, J.2    Gabriel, R.3
  • 88
    • 84961061763 scopus 로고    scopus 로고
    • Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
    • On behalf of EUROACTION Study Group
    • Wood D.A., Kotseva K., Connolly S., Jennings C., Mead A., Jones J., et al., On behalf of EUROACTION Study Group. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 371 (2008) 1999-2012
    • (2008) Lancet , vol.371 , pp. 1999-2012
    • Wood, D.A.1    Kotseva, K.2    Connolly, S.3    Jennings, C.4    Mead, A.5    Jones, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.